Will Trump put alternative energy on a level-playing field?

Minimal impact on alternative energy

clock • 2 min read

Donald Trump's election as US President last November created uncertainty for alternative energy investors due to his anti-environmental, pro-coal stance, writes Guinness Asset Management analyst Samira Rüdig-Sotomayor.

The main alternative energy policies at risk are the Investment and Production Tax Credits, as well as the Clean Power Plan (CPP). The tax credits were extended in the Omnibus Spending Bill in 2015, which had bipartisan support in Congress. The Republican support for these measures could make removing the subsidies challenging.  These tax credits already have a phase-out schedule in place until they are fully removed between 2019 and 2022. Trump may therefore choose to expend his political capital elsewhere.  The CPP supports the US alternative energy sector in the 2020s, but has a...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot